E7046

E7046
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TQ0025-5mg 5 mg

7 - 10 business days*

48.00€
TGM-TQ0025-10mg 10 mg

7 - 10 business days*

67.00€
TGM-TQ0025-25mg 25 mg

7 - 10 business days*

130.00€
TGM-TQ0025-50mg 50 mg

7 - 10 business days*

223.00€
 
Description: E7046 is a specific, orally bioavailable EP4 antagonist (IC50: 13.5 nM, Ki: 23.14... more
Product information "E7046"
Description: E7046 is a specific, orally bioavailable EP4 antagonist (IC50: 13.5 nM, Ki: 23.14 nM), exhibiting anti-tumor activities. Target: Prostaglandin Receptor. Smiles: C[C@H](NC(=O)c1c(nn(C)c1Oc1cccc(c1)C(F)(F)F)C(F)F)c1ccc(cc1)C(O)=O. References: Diana I. Albu, et al. EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity. OncoImmunology.
Supplier: TargetMol
Supplier-Nr: TQ0025

Properties

Application: EP4 antagonist
MW: 483.4 D
Formula: C22H18F5N3O4

Database Information

CAS : 1369489-71-3| Matching products
KEGG ID : K04261 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "E7046"
Write a review
or to review a product.
Viewed